Takeda Pharmaceuticals America, Inc. NDCs and Package Codes
This page lists NDC package records associated with labeler code 47783 (Takeda Pharmaceuticals America, Inc.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.
Key stats
4
Package NDCs
6
Products
6
Active listings
0
Discontinued
2
Ingredients
0
Therapeutic classes
2
Dosage forms
0
With NADAC pricing
Portfolio
Top ingredients
By dosage form
Browse records — 6 products
| Drug / product | Billing NDC | NADAC / unit | Status | |
|---|---|---|---|---|
| Kalbitor Ecallantide 10 mg/mL INJECTION, SOLUTION | 47783-0101-01 | — | On market | View → |
| TAKHZYRO lanadelumab-flyo 300 mg/2mL INJECTION, SOLUTION | 47783-0644-01 | — | Discontinued | View → |
| TAKHZYRO lanadelumab-flyo 150 mg/mL SOLUTION | 47783-0645-01 | — | On market | View → |
| TAKHZYRO lanadelumab-flyo 300 mg/2mL SOLUTION | 47783-0646-01 | — | On market | View → |
| TAKHZYRO lanadelumab-flyo 300 mg/2mL SOLUTION | 47783-0646-01 | — | On market | View → |
| TAKHZYRO lanadelumab-flyo 150 mg/mL SOLUTION | 47783-0645-01 | — | On market | View → |
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.